Бронхолегочные осложнения заболеваний нервно-мышечной системы: клинические рекомендации Испанского общества пульмонологов и торакальных хирургов
Аннотация
По материалам: Farrero E., Antуn A., Egea C.J. et al. Guidelines for the management of respiratory complications in patients with neuromuscular disease. Arch. Bronconeumol. 2013; 49 (7): 306–313.
Список литературы
1. Howard R.S., Wiles C.M., Hirsch N.P., Spencer G.T. Respiratory involvement in primary muscle disorders: assessment and management. Quart. J. Med. 1993; 86: 175–189.
2. Simonds A.K. Recent advances in respiratory care for neuromuscular disease. Chest 2006; 130: 1879–1886.
3. Farrero E., Prats E., Povedano M. et al. Survival in amyotrophic lateral sclerosis with home mechanical ventilation: the impact of systematic respiratory assessment and bulbar involvement. Chest 2005; 127: 2132–2138.
4. Schünemann H.J., Jaeschke R., Cook D. et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am. J. Crit. Care Med. 2006; 174: 605–614.
5. Ambrosino N., Carpené N., Gherardi M. Chronic respiratory care for neuromuscular diseases in adults. Eur. Respir. J. 2009; 34: 444–451.
6. Díaz7Lobato S., Ruiz7Cobos A., García Rýo F.J., Villamor Leуn J. Fisiopatologia de la insuficiencia respiratoria de origen neuromuscular. Rev. Neurol. 2001; 32: 91–95.
7. Rabinstein A.A. Update on respiratory management of critically ill neurologic patients. Curr. Neurol. Neurosci. Rep. 2005; 5: 476–482.
8. Miller R.G., Jackson C.E., Kasarskis E.J. et al. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009; 73: 1218–1226.
9. Vincken W.G., Elleker M.G., Cosio M.G. Flow-volume loop changes reflecting respiratory muscle weakness in chronic neuromuscular disorders. Am. J. Med. 1987; 83: 673–680.
10. Hughes R.A., Wijdicks E.F., Benson E. et al. Multidisciplinary Consensus Group. Supportive care for patients with Guillain-Barré syndrome. Arch. Neurol. 2005; 62: 1194–1198.
11. Mayos M., Giner J., Casan P., Sanchis J. Measurement of maximal static respiratory pressures at the mouth with different air leaks. Chest 1991; 100: 364–366.
12. Servera E., Sancho J., Zafra M.J. Tos y enfermedades neuromusculares. Manejo no invasivo de las secreciones respiratorias. Arch. Bronconeumol. 2003; 39: 418–427.
13. Morgan R.K., McNally S., Alexander M. et al. Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am. J. Respir. Crit. Care Med. 2005; 171: 269–274.
14. Hart N., Sylvester K., Ward S. et al. Evaluation of an inspiratory muscle trainer in healthy humans. Respir. Med. 2001; 95: 526–531.
15. Lloyd T., Tang Y.M., Benson M.D., King S. Diaphragmatic paralysis: the use of M mode ultrasound for diagnosis in adults. Spinal Cord 2006; 44: 505–508.
16. AGA technical review on management of oropharyngeal dysphagia. Gastroenterology 1999; 116: 455–478.
17. Clavé P., Arreola A., Velasco M. et al. Diagnуstico y tratamiento de la disfagia orofaringea funcional. Aspectos de interés para el cirujano digestivo. Cir. Esp. 2007; 82: 64–77.
18. Lim S.H.B., Lieu P.K., Phua S.Y. et al. Accuracy of bedside clinical methods compared with fiberoptic endoscopic examination of swallowing (FEES) in determining the risk of aspiration in acute stroke patients. Dysphagia 2001; 16: 1–6.
19. Bhakta D., Groh W.J. Cardiac function tests in neuromuscular diseases. Neurol. Clin. 2004; 22: 591–617.
20. Goldstein L.B., El Husseini N. Neurology and cardiology: points of contact. Rev. Esp. Cardiol. 2011; 64: 319–327.
21. Gregoratos G., Abrams J., Epstein A. et al. ACC / AHA / NASPE 2002 Guideline update for implantation of cardiac pacemarkers and antiarrhythmia device. Circulation 2002; 106: 2145–2161.
22. Kang S.W., Bach J.R. Maximum insufflation capacity: the relationships with vital capacity and cough flows for patients with neuromuscular disease. Am. J. Phys. Med. Rehabil. 2000; 79: 222–227.
23. Ishikawa Y., Bach J.R. Physical medicine respiratory muscle aids to avert respiratory complications of pediatric chest wall and vertebral deformity and muscle dysfunction. Eur. J. Phys. Rehabil. Med. 2010; 46: 581–597.
24. Laffont I., Bensmail D., Lortat7Jacob S. Intermittent positive-pressure breathing effects in patients with high spinal cord injury. Arch. Phys. Med. Rehab. 2008; 89: 1575–1579.
25. Guerin C., Vincent B., Petitjean T. et al. The short-term effects of intermittent positive pressure breathing treatments on ventilation in patients with neuromuscular disease. Respir. Care 2010; 55: 866–872.
26. AARC Clinical Practice Guideline. Intermittent positive pressure breathing-2003 revision & update. Respir. Care 2003; 48: 540–546.
27. Bento J., Gonçalves M., Silva N. et al. Indications and compliance of home mechanical insufflation-exsufflation in patients with neuromuscular diseases. Arch. Bronconeumol. 2010; 46: 420–425.
28. Sancho J., Servera E., Díaz J., Marín J. Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis. Chest 2004; 125: 1400–1405.
29. Annane D., Quera7Salva M.A., Lofaso F. et al. Mechanisms underlying the effects of nocturnal ventilation on daytime blood gases in neuromuscular diseases. Eur. Respir. J. 1999; 13: 157–162.
30. Nickol A.N., Hart N., Hopkinson N.S. et al. Mechanisms of improvement of respiratory failure in patients with restrictive thoracic disease treated with non-invasive ventilation. Thorax 2005; 60: 754–760.
31. Hess D.R. Noninvasive ventilation in neuromuscular diseases: equipment and application. Respir. Care 2006; 51: 896–912.
32. Make B., Hill N., Goldberg A. et al. Mechanical ventilation beyond the intensive care unit. Report of a Consensus Conference of the American College of Chest Physicians. Chest 1998; 113: 289–344.
33. Kohorts J., Blakely P., Dockter C., Pruit W. AARC clinical practice guideline: longterm invasive mechanical ventilation in home-2007 revision & update. Respir. Care 2007; 52: 1056–1062.
34. McKim D.A., Road J., Avendano M. et al. Home mechanical ventilation: a Canadian Thoracic Society Clinical Practice Guideline. Can. Respir. J. 2011; 18: 197–215.
35. Sancho J., Servera E., Dás J.L. et al. Home tracheotomy mechanical ventilation in patients with amyotrophic lateral sclerosis: causes, complications and 1-year survival. Thorax 2011; 66: 948–952.
36. Antequera J.M., Barbero J., Bátiz J. et al. Ética en cuidados paliativos. Guias de ética en la práctica clinica. Fundaciуn de Ciencias de la Salud. Available from: www.saludcastillayleon.es [accessed 25.01.13].
37. Meisel A., Snyder L., Quill T. Seven legal barriers to end-of-life care: myths, realities, and grains of truth. J.A.M.A. 2000; 284: 2495–2501.
38. Lanken P., Terry P., DeLisser H.M. An Official American Thoracic Society Clinical Policy Statement: palliative care for patients with respiratory diseases and critical illnesses. Am. J. Respir. Crit. Care Med. 2008; 177: 912–927.
39. Aguilar M., Badenes D., Gelonch O. Enfermedades neurolуgicas crуnicas y abordaje interdisciplinar. Summa Neurol. 2002; 1: 38–41.
40. Escarrabill J., Dáz S., Masa J.F. et al. Hospital based longterm home respiratory care in Spain. Chest 1999; 116 (Suppl.): 318.
41. Escarrabill J., Farrero E., Prats E. Unidad funcional respiratoria multidisciplinar. Med. Clin. (Barc.). 1996; 107: 438–439.
42. Corr B., Frost E., Traynor B.J., Hardiman O. Service provision for patients with ALS/MND: a cost-effective multidisciplinary approach. J. Neurol. Sci. 1998; 160 (Suppl. 1): S141–S145.
43. Traynor B.J., Alexander M., Corr B. et al. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000. J. Neurol. Neurosurg. Psychiatry. 2003; 74: 1258–1261.
44. Zoccolella S., Beghi E., Palagano G. et al. ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy. J. Neurol. 2007; 254: 1107–1112.
Для цитирования:
Бронхолегочные осложнения заболеваний нервно-мышечной системы: клинические рекомендации Испанского общества пульмонологов и торакальных хирургов. Пульмонология. 2013;(6):11-20. https://doi.org/10.18093/0869-0189-2013-0-6-704-712
For citation:
. Pulmonary complications of neuromuscular disease: clinical guidelines of the Spanish society of pulmonology and thoracic surgery. PULMONOLOGIYA. 2013;(6):11-20. (In Russ.) https://doi.org/10.18093/0869-0189-2013-0-6-704-712
Просмотров: 535
Послать статью по эл. почте 